| Next 10 |
CALA News and Press, Calithera Biosciences Inc.
-
SOUTH SAN FRANCISCO, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage, precision oncology biopharmaceutical company, today announced that Susan Molineaux, Ph.D., the company’s founder, president and chief executive officer, will pr...
-
InvestorPlace - Stock Market News, Stock Advice & Trading Tips We’re starting off the final day of the workweek with an overview of the biggest pre-market stock movers for Friday! Source: f11photo/Shutterstock.com A statement from Elon Musk, several earnings reports, and...
-
Calithera Biosciences (NASDAQ:CALA) stock plunges after Ladenburg analyst Aydin Huseynov lowered the price target to $1.50 from $3 and maintains a Buy rating on the shares after its Q1 results. The company is developing two recently in-licensed oncology assets simultaneously, but th...
-
Image source: The Motley Fool. Calithera Biosciences (NASDAQ: CALA) Q1 2022 Earnings Call May 10, 2022 , 5:00 p.m. ET Operator Continue reading For further details see: Calithera Biosciences (CALA) Q1 2022 Earnings Call Transcript
-
Calithera Biosciences, Inc. (CALA) CEO Susan Molineaux on Q1 2022 Results - Earnings Call Transcript
Calithera Biosciences, Inc. (CALA) Q1 2022 Earnings Conference Call May 10, 2022, 05:00 PM ET Company Participants Susan Molineaux - Founder, President & CEO Stephanie Wong - CFO Emil Kuriakose - Chief Medical Officer Conference Call Participants Jonathan Chang - SVB Leerink Nick Abbott -...
-
Calithera Biosciences press release (NASDAQ:CALA): Q1 GAAP EPS of -$0.18 in-line. Net loss for the three months ended March 31, 2022 was $13.8 million. Cash and cash equivalents totaled $44.7 million at March 31, 2022, which Calithera expects, together with proceeds from its public offering, ...
-
-- Conference Call and Webcast Scheduled for 2:00 p.m. PT / 5:00 p.m. ET on Tuesday, May 10, 2022 -- SOUTH SAN FRANCISCO, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage, precision-oncology biopharmaceutical company, today announced ...
-
SOUTH SAN FRANCISCO, Calif., May 03, 2022 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage, precision oncology biopharmaceutical company, today announced that the Company’s first quarter 2022 financial results will be released on Tuesday, May 10, 2022....
-
3 Under $1 Penny Stocks to Watch in May 2022 Finding the best penny stocks to buy under $1 is all about doing your due diligence and finding the most promising companies with good prospects for future growth. Because penny stocks are so speculative, understanding exactly what is goi...
-
Findings presented today at AACR Annual Meeting detail Calithera discovery of VPS4A inhibitors and their potential as a therapeutic approach in numerous solid tumor cancers VPS4A and VPS4B are gene paralogs that show strong synthetic lethal interaction SOUTH SAN FRANCISCO,...
Stock Information
Calithera Biosciences Inc. Company Name:
CALA Stock Symbol:
NASDAQ Market:
Calithera Biosciences Inc. Website:
MENU
CALA
CALA Quote
CALA Short
CALA News
CALA Articles
Get CALA Alerts
News, Short Squeeze, Breakout and More Instantly...
-
SOUTH SAN FRANCISCO, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage, precision oncology biopharmaceutical company, today announced that Susan Molineaux, Ph.D., the company’s founder, president and chief executive officer, will pr...
-
InvestorPlace - Stock Market News, Stock Advice & Trading Tips We’re starting off the final day of the workweek with an overview of the biggest pre-market stock movers for Friday! Source: f11photo/Shutterstock.com A statement from Elon Musk, several earnings reports, and...
-
Image source: The Motley Fool. Calithera Biosciences (NASDAQ: CALA) Q1 2022 Earnings Call May 10, 2022 , 5:00 p.m. ET Operator Continue reading For further details see: Calithera Biosciences (CALA) Q1 2022 Earnings Call Transcript